Cytokine Mixture for Immunomodulation (TNF and Growth Factors)
Bulk mixed solution of tumor necrosis factors (TNF) and growth factors for regulating immune responses in clinical settings. HTS 3002.14.00.90 applies to these mixed immunological products (TNF/GF per notes) not in retail forms.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If antisera or blood fractions rather than cytokines
Antisera subheading 3002.12 for non-immunological blood products; cytokines are distinct immunologicals.
If in measured doses for opacifying or diagnostic admin
Chapter note 6(d) routes patient-administered diagnostic mixes to 3006.
If industrial enzyme use vs therapeutic
Non-therapeutic peptides/proteins classify as enzymes in 3504.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Submit FDA import alert 81-01 documentation for biotech-derived products
• Verify mixture status with HPLC analysis reports to confirm 3002.14 classification
Related Products under HTS 3002.14.00.90
Antibody Fragment Conjugate Mixture for Targeted Therapy
Blend of antibody fragments and conjugates for precise immune targeting in autoimmune diseases. HTS 3002.14.00.90 for mixed, non-retail immunological products including antibody conjugates per chapter notes.
Mixed Monoclonal Antibody Cocktail for Cancer Immunotherapy
This product is a blend of multiple monoclonal antibodies (e.g., pembrolizumab and nivolumab derivatives) designed for immunotherapy treatment of solid tumors. It falls under HTS 3002.14.00.90 as mixed immunological products not in measured doses or retail packaging, per chapter notes defining immunological products as peptides/proteins regulating immunological processes.
Blended Interferon-Alpha and Interleukin-2 Therapy
A mixed preparation of recombinant interferon-alpha and interleukin-2 for treating viral infections and boosting immune response in immunotherapy. Classified in HTS 3002.14.00.90 as mixed immunological products (interferons and interleukins per chapter notes) not for retail sale.
Hematopoietin and Colony Stimulating Factor Blend
Mixed hematopoietins and colony stimulating factors (CSF) for bone marrow stimulation in chemotherapy patients. Fits HTS 3002.14.00.90 as mixed biotech immunological products for bulk clinical use.